According to a new report by MarketsandMarkets™ - Oligonucleotide Synthesis Market in terms of revenue was estimated to be worth $8.8 billion in 2024 and is poised to reach $19.7 billion by 2029, growing at a CAGR of 17.5% from 2024 to 2029. One of the key factors driving the market growth is the growing acceptance of alternate therapies such as oligonucleotide-based therapies...